MedTrace Logo

PEDİATRİC MİGRAİNE PATİENTS İN FİNDİNGS

NCT07593287 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2026-05-18

No results posted yet for this study

Summary

Migraine is a common neurological disease in the pediatric population. However, studies investigating the clinical symptoms associated with the different phases of migraine attacks (prodrome, aura, postdrome), particularly in childhood and adolescence, remain limited. The aim of this study was to evaluate the clinical symptoms experienced by children with migraine during attack phases (prodrome, aura, postdrome) and to investigate potential differences in these symptoms according to age and gender The first 18 questions assessed sociodemographic variables, including age, sex, body weight, parental characteristics, social status, age at migraine diagnosis and symptoms, knowledge of migraine, family history of migraine, comorbid conditions, and access to healthcare services. The second part of the questionnaire consisted of questions on headache and migraine-related symptoms and clinical characteristics (questions 19-26), migraine treatment (questions 28-34), and postdrome features (questions 35-39). The study examined migraine-related symptoms and clinical characteristics, treatment approaches, and the influence of sex and age group on the stages of migraine.

All patients underwent an assessment of headaches within the last three months, along with physical and neurological examinations. The diagnosis of migraine was made according to the ICHD-III criteria.

Conditions

Sponsors & Collaborators

  • Mersin University

    lead OTHER

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-09-01
Completion
2021-12-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07593287 on ClinicalTrials.gov